Based on recent data, Immix Biopharma, Inc. (IMMX) shows an Average True Range (ATR) of 0.57 and an Enterprise Value of 38.71M. Its average trading volume over the past 3 months is 834.08K, indicating liquidity. These fundamental metrics provide insight into IMMX's underlying financial health and market activity.
| ATR | 0.57 |
| Enterprise Value | 38.71M |
| Avg Vol (3 Months) | 834.08K |
| Avg Vol (10 Days) | 616.97K |
Immix Biopharma, Inc. (IMMX) technical indicators as of April 16, 2026: the SMA 20 is 18.32%, SMA 50 at 40.13%, and SMA 200 at 133.52%. The RSI 14 value is 70.58, suggesting its current momentum. These technical analysis signals help assess IMMX's price trends and potential future movements.
| SMA 20 | 18.32% |
| SMA 50 | 40.13% |
| SMA 200 | 133.52% |
| RSI 14 | 70.58 |
Immix Biopharma, Inc. (IMMX) stock performance overview as of April 16, 2026: The 52-week high is $11.61 (currently -5.35% below), and the 52-week low is $1.6 (currently 533.58% above). Over the past year, IMMX's performance is 123.3%, compared to the S&P 500's 25.19% change.
| 52-Week High | 11.61 |
| 52-Week High Chg | -5.35% |
| 52-Week Low | 1.6 |
| 52-Week Low Chg | +533.58% |
| S&P 500 52-Week Chg | 25.19% |
According to market data, Immix Biopharma, Inc. (IMMX) stock's recent performance metrics show that over the last month, IMMX is -17.27%, with a Year-to-Date (YTD) performance of -12.05%. Over the past year, the stock has seen a 123.3% change. These figures summarize IMMX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.15 | 11.61 | 11.61 | 11.61 | 11.61 | 11.61 |
| Low | 8.54 | 8 | 4.18 | 2.26 | 1.6 | 4.18 |
| Performance | +3.60% | -17.27% | +60.28% | +53.85% | +123.30% | -12.05% |
According to current financial data, IMMX stock's P/E (TTM) ratio is -12.76, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for IMMX, including P/S (N/A), P/B (4.00), and P/FCF (-21.07), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IMMX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -12.76 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 4 | 3.44 | 0.29 | 4.95 |
| P/FCF (TTM) | -21.07 | -2.42 | -554.58 | 34.42 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep